Find the latest news and articles regarding UCA
3/27/2020
So, you’ve got localized prostate cancer, you’ve decided to get it treated with either surgery or radiation, and you have steeled yourself to get on with it. You’ve been through a lot already: from the […]
3/23/2020
UCA continues its efforts to keep the safety of our patients and team members as our highest priority. In order to comply with the order from the Jefferson County Department of Health most recent order, […]
3/16/2020
Due to the COVID- 19 pandemic, we are taking the following precautions to protect our patients and staff. Effective Monday March 16, 2020, UCA will begin making the following operational changes in response to the […]
3/10/2020
Thank you for trust you have placed in Urology Centers of Alabama and the UCA Women’s Center. As always, it is a privilege to be your urologic heath care partner. As the novel coronavirus’ (COVID-19) […]
3/6/2020
Published 9:35 pm Wednesday, March 4, 2020 All Pike County men, ages 40 and over, are encouraged to set aside as few minutes on Saturday to take a simple test that could save their lives. […]
2/14/2020
Valentine’s Day is just around the corner. While it is customary for men to get women gifts for this special day, many women will be trying to figure out a way to show their man […]
1/9/2020
“At UCA, we continue to drive state of the art care. As a clinical trial site, interested and qualifying patients had the opportunity to participate in the clinical trial which led to the recent FDA […]
12/18/2019
UCA partnered with the Mike Slive Foundation to offer free PSA blood screenings at the Mike Slive Invitational. As basketball fans enjoyed the game of Auburn vs. St. Louis University, we screened over 60 men […]
10/9/2019
On September 17, 2019, the Food and Drug Administration approved apalutamide (ERLEADA, Janssen Biotech, Inc) for patients with metastatic castration-sensitive prostate cancer (mCSPC). Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate […]